Epiitalis®, the proprietary ingredient in Epijoint®, is harnessed from a plant seed oil, comprised of fatty acids. Epiitalis® is globally patented for its anti-inflammatory properties and cartilage health benefits.

The recommended daily dosage is 2 capsules per day. Up to 4 capsules can be taken if necessary.

Talk to your prescribing medical practitioner before taking other medicines.

Epijoint® is currently only available to purchase on-line via the Epijoint® online store.

While individual results vary, most people report an improvement in 7 to 30 days after consistent daily use.

Do not use if breastfeeding, pregnant or likely to become pregnant.

Epijoint® does not contain gluten, nuts, dairy or marine ingredients, however it contains low traces of soya bean products and sulfites.

Epijoint® is manufactured in a GMP factory In New South Wales, Australia. The company behind Epijoint®, Interpath Global, is also Australian owned, located, and managed.

Epijoint® should be stored below 25 degrees and away from direct heat, moisture, or sunlight.

We have not conducted official studies that specifically examine the effects of Epijoint® on spinal joint injuries.

All batches of Epijoint® are manufactured at a GMP factory and tested thoroughly for quality at several points during the production process to ensure all product meets industry standards.   

No, Epijoint® is not formulated for use in pets. Our 4CYTE™ animal range has been developed specifically to promote healthier joints in pets and is also powered by Epiitalis® – the same active ingredient in Epijoint®. We recommend that you discuss specific pet issues with your veterinarian, who will provide professional advice and may be able to recommend the appropriate 4CYTE™ treatment to assist your pet’s mobility.